Resumen de Infliximabe no tratamento da psoríase associada a doença de Crohn. Relato de caso
Joao Roberto Antonio, Natalia Cristina Pires Rossi, Fabiola Leme Azevedo, Guilherme Bueno De Oliveira, Carlos Roberto Antonio
Therapy with inhibitors of tumor necrosis factor provide beneficial effects in various inflammatory immune diseases. We report the case of a man carrying Crohn’s disease six years ago and five years with severe psoriasis. He was elected for the use of infliximab, justified by the combination of two chronic inflammatory diseases. After 23 doses the patient is totally without skin lesions and satisfied with the improvement in quality of life and symptoms control of Crohn’s disease.
